Cas 1116134-69-0,(1S,2R)-N-{1-benzyl-2-hydroxy-3-(S)-[2-(1-benzylpiperidin-4-yl)ethylamino]-propyl}-N',N'-dipropylisophthalamide

1116134-69-0

Post Buying Request

Basic information

Product Name: (1S,2R)-N-{1-benzyl-2-hydroxy-3-(S)-[2-(1-benzylpiperidin-4-yl)ethylamino]-propyl}-N',N'-dipropylisophthalamide
Synonyms:
CAS NO:1116134-69-0
Molecular Formula:
Molecular Weight: 612.856
EINECS: N/A
Product Categories: N/A
Mol File: 1116134-69-0.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (1S,2R)-N-{1-benzyl-2-hydroxy-3-(S)-[2-(1-benzylpiperidin-4-yl)ethylamino]-propyl}-N',N'-dipropylisophthalamide(CAS DataBase Reference)
NIST Chemistry Reference: (1S,2R)-N-{1-benzyl-2-hydroxy-3-(S)-[2-(1-benzylpiperidin-4-yl)ethylamino]-propyl}-N',N'-dipropylisophthalamide(1116134-69-0)
EPA Substance Registry System: (1S,2R)-N-{1-benzyl-2-hydroxy-3-(S)-[2-(1-benzylpiperidin-4-yl)ethylamino]-propyl}-N',N'-dipropylisophthalamide(1116134-69-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1116134-69-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1116134-69-0 Suppliers

Recommended suppliersmore

1116134-69-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1116134-69-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,1,6,1,3 and 4 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1116134-69:
(9*1)+(8*1)+(7*1)+(6*6)+(5*1)+(4*3)+(3*4)+(2*6)+(1*9)=110
110 % 10 = 0
So 1116134-69-0 is a valid CAS Registry Number.

1116134-69-0Upstream product

126926-35-0 N,N-Dipropylisophthalamic acid

1116134-69-0Downstream Products

1116134-69-0Relevant articles and documents

Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and β-secretase

Zhu, Yiping,Xiao, Kun,Ma, Lanping,Xiong, Bin,Fu, Yan,Yu, Haiping,Wang, Wei,Wang, Xin,Hu, Dingyu,Peng, Hongli,Li, Jingya,Gong, Qi,Chai, Qian,Tang, Xican,Zhang, Haiyan,Li, Jia,Shen, Jingkang

experimental part, p. 1600 - 1613 (2009/09/30)

To explore novel effective drugs for the treatment of Alzheimer's disease (AD), a series of dual inhibitors of acetylcholineterase (AChE) and β-secretase (BACE-1) were designed based on the multi-target-directed ligands strategy. Among them, inhibitor 28

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1116134-69-0